US Stock MarketDetailed Quotes

Prime Medicine (PRME)

Watchlist
  • 3.330
  • +0.040+1.22%
Close Feb 19 16:00 ET
601.10MMarket Cap-2.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Prime Medicine (PRME) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
486.12%1.23M
1.12M
146.02%1.45M
2.98M
2.18M
209K
0
591K
0
0
Operating revenue
486.12%1.23M
--1.12M
146.02%1.45M
--2.98M
--2.18M
--209K
--0
--591K
--0
--0
Cost of revenue
Gross profit
Operating expense
1.39%55.2M
-2.12%54.49M
10.04%53.85M
7.40%205.45M
-14.92%46.41M
5.79%54.44M
23.01%55.67M
22.23%48.93M
64.14%191.29M
40.99%54.54M
Selling and administrative expenses
-20.52%11.21M
4.09%13.12M
19.05%13.28M
15.61%50.16M
-5.98%12.3M
34.38%14.1M
18.23%12.6M
21.91%11.16M
45.50%43.39M
35.94%13.08M
-General and administrative expense
-20.52%11.21M
4.09%13.12M
19.05%13.28M
15.61%50.16M
-5.98%12.3M
34.38%14.1M
18.23%12.6M
21.91%11.16M
45.50%43.39M
35.94%13.08M
Research and development costs
9.05%43.99M
-3.94%41.38M
7.38%40.56M
4.99%155.29M
-17.74%34.1M
-1.53%40.34M
24.49%43.07M
22.33%37.77M
70.54%147.91M
42.66%41.46M
Operating profit
0.48%-53.97M
4.12%-53.38M
-8.38%-52.39M
-5.84%-202.47M
18.92%-44.22M
-5.39%-54.23M
-23.01%-55.67M
-20.75%-48.34M
-64.14%-191.29M
-40.99%-54.54M
Net non-operating interest income expense
63.70%1.14M
21.60%743K
74.85%1.18M
25.29%3.52M
213.24%1.54M
70.00%697K
-3.78%611K
676K
2.81M
491K
Non-operating interest income
63.70%1.14M
21.60%743K
74.85%1.18M
25.29%3.52M
213.24%1.54M
70.00%697K
-3.78%611K
--676K
--2.81M
--491K
Other net income (expense)
121.24%2.25M
110.75%43K
-133.37%-680K
130.84%3.06M
103.52%408K
336.48%1.02M
-117.64%-400K
369.59%2.04M
-59.53%-9.93M
-1,380.33%-11.59M
Gain on sale of security
576.28%1.45M
73.77%-505K
-190.57%-1.06M
79.64%-485K
-90.71%59K
113.62%215K
-831.94%-1.93M
168.55%1.17M
70.69%-2.38M
137.16%635K
Special income (charges)
----
----
----
--0
----
----
----
----
---13.5M
----
-Less:Other special charges
----
----
----
----
----
----
----
----
--13.5M
----
Other non- operating income (expenses)
153.01%44K
-53.85%18K
-11.90%37K
-85.04%41K
-70.95%43K
-293.02%-83K
-4.88%39K
-98.03%42K
-85.60%274K
-84.02%148K
Income before tax
3.69%-50.58M
5.17%-52.59M
-13.73%-51.89M
1.28%-195.88M
35.60%-42.28M
-3.35%-52.52M
-30.95%-55.46M
-15.22%-45.63M
-61.61%-198.41M
-66.32%-65.64M
Income tax
0
0
0
0
0
-532.26%-134K
166.34%134K
70.57%-279K
0
Net income
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
1.14%-195.88M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-62.64%-198.13M
-67.10%-65.64M
Net income continuous Operations
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
1.14%-195.88M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-62.64%-198.13M
-67.10%-65.64M
Minority interest income
Net income attributable to the parent company
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
1.14%-195.88M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-62.64%-198.13M
-67.10%-65.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
1.14%-195.88M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-39.52%-198.13M
-61.69%-65.64M
Basic earnings per share
27.27%-0.32
10.87%-0.41
9.09%-0.4
24.31%-1.65
56.94%-0.31
20.00%-0.44
2.13%-0.46
0.00%-0.44
47.97%-2.18
-28.57%-0.72
Diluted earnings per share
27.27%-0.32
10.87%-0.41
9.09%-0.4
24.31%-1.65
56.94%-0.31
20.00%-0.44
2.13%-0.46
0.00%-0.44
47.97%-2.18
-28.57%-0.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 486.12%1.23M1.12M146.02%1.45M2.98M2.18M209K0591K00
Operating revenue 486.12%1.23M--1.12M146.02%1.45M--2.98M--2.18M--209K--0--591K--0--0
Cost of revenue
Gross profit
Operating expense 1.39%55.2M-2.12%54.49M10.04%53.85M7.40%205.45M-14.92%46.41M5.79%54.44M23.01%55.67M22.23%48.93M64.14%191.29M40.99%54.54M
Selling and administrative expenses -20.52%11.21M4.09%13.12M19.05%13.28M15.61%50.16M-5.98%12.3M34.38%14.1M18.23%12.6M21.91%11.16M45.50%43.39M35.94%13.08M
-General and administrative expense -20.52%11.21M4.09%13.12M19.05%13.28M15.61%50.16M-5.98%12.3M34.38%14.1M18.23%12.6M21.91%11.16M45.50%43.39M35.94%13.08M
Research and development costs 9.05%43.99M-3.94%41.38M7.38%40.56M4.99%155.29M-17.74%34.1M-1.53%40.34M24.49%43.07M22.33%37.77M70.54%147.91M42.66%41.46M
Operating profit 0.48%-53.97M4.12%-53.38M-8.38%-52.39M-5.84%-202.47M18.92%-44.22M-5.39%-54.23M-23.01%-55.67M-20.75%-48.34M-64.14%-191.29M-40.99%-54.54M
Net non-operating interest income expense 63.70%1.14M21.60%743K74.85%1.18M25.29%3.52M213.24%1.54M70.00%697K-3.78%611K676K2.81M491K
Non-operating interest income 63.70%1.14M21.60%743K74.85%1.18M25.29%3.52M213.24%1.54M70.00%697K-3.78%611K--676K--2.81M--491K
Other net income (expense) 121.24%2.25M110.75%43K-133.37%-680K130.84%3.06M103.52%408K336.48%1.02M-117.64%-400K369.59%2.04M-59.53%-9.93M-1,380.33%-11.59M
Gain on sale of security 576.28%1.45M73.77%-505K-190.57%-1.06M79.64%-485K-90.71%59K113.62%215K-831.94%-1.93M168.55%1.17M70.69%-2.38M137.16%635K
Special income (charges) --------------0-------------------13.5M----
-Less:Other special charges ----------------------------------13.5M----
Other non- operating income (expenses) 153.01%44K-53.85%18K-11.90%37K-85.04%41K-70.95%43K-293.02%-83K-4.88%39K-98.03%42K-85.60%274K-84.02%148K
Income before tax 3.69%-50.58M5.17%-52.59M-13.73%-51.89M1.28%-195.88M35.60%-42.28M-3.35%-52.52M-30.95%-55.46M-15.22%-45.63M-61.61%-198.41M-66.32%-65.64M
Income tax 00000-532.26%-134K166.34%134K70.57%-279K0
Net income 3.69%-50.58M4.95%-52.59M-13.39%-51.89M1.14%-195.88M35.60%-42.28M-3.57%-52.52M-30.53%-55.33M-16.15%-45.76M-62.64%-198.13M-67.10%-65.64M
Net income continuous Operations 3.69%-50.58M4.95%-52.59M-13.39%-51.89M1.14%-195.88M35.60%-42.28M-3.57%-52.52M-30.53%-55.33M-16.15%-45.76M-62.64%-198.13M-67.10%-65.64M
Minority interest income
Net income attributable to the parent company 3.69%-50.58M4.95%-52.59M-13.39%-51.89M1.14%-195.88M35.60%-42.28M-3.57%-52.52M-30.53%-55.33M-16.15%-45.76M-62.64%-198.13M-67.10%-65.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.69%-50.58M4.95%-52.59M-13.39%-51.89M1.14%-195.88M35.60%-42.28M-3.57%-52.52M-30.53%-55.33M-16.15%-45.76M-39.52%-198.13M-61.69%-65.64M
Basic earnings per share 27.27%-0.3210.87%-0.419.09%-0.424.31%-1.6556.94%-0.3120.00%-0.442.13%-0.460.00%-0.4447.97%-2.18-28.57%-0.72
Diluted earnings per share 27.27%-0.3210.87%-0.419.09%-0.424.31%-1.6556.94%-0.3120.00%-0.442.13%-0.460.00%-0.4447.97%-2.18-28.57%-0.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.77%
Sample Name
Sample Code
 +2.19%
Sample Name
Sample Code
 +1.53%
4
Vistra Energy
VST
+1.13%
5
Dropbox
DBX
+0.20%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +8.20%
Sample Name
Sample Code
 +5.52%
Sample Name
Sample Code
 +4.27%
4
Chagee Holdings
CHA
+2.33%
5
ZTO Express
ZTO
+2.25%
View More
Trump cheers on towards 100,000! Will the Dow continue its surge after breaking through 50,000 point
On February 10 Eastern Time, the Dow Jones Industrial Average hit another all-time high! Previously, on February 6, the Dow surpassed the hi Show More
Is the US stock market entering a recovery phase? Trump and Jensen Huang both 'chiming in' with these three key trends worth watching!
Wait for the right moment to act

- No more -